PharmaShots | Incisive News in 3 Shots

Subscribe Now

Kazia

Kazia Reports Positive Final Data From P-II Study of Paxalisib to Treat Patients with Glioblastoma

Kazia Reports Positive Final Data From P-II Study of Paxalisib to Treat Patients with Glioblastoma

December 6, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us